Prostatic Hypertrophy, Benign Completed Phase 4 Trials for Alfuzosin (DB00346)

Also known as: Benign Prostatic Hypertrophy (BPH) / Benign Prostatic Hypertrophy / BPH / Prostatic hypertrophy (benign) / Benign prostatic hyperplasia / Enlarged prostate (benign)

IndicationStatusPhase
DBCOND0029457 (Prostatic Hypertrophy, Benign)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00696761The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH PatientsTreatment